Phase 2 Bladder Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• (Phase 1b only) People of any gender who have been diagnosed with non-muscle invasive bladder cancer (an early stage of bladder cancer that has not spread into the bladder muscle, classified as stage Ta, Tis, or T1) and are currently in the early treatment phase using one of these treatments: Gemcitabine, sequential gemcitabine/docetaxel, Bacillus Calmette-Guerin (BCG), or Mitomycin C delivered directly into the bladder
• (Phase 2 only) People of any gender who have been diagnosed with non-muscle invasive bladder cancer (stage Ta, Tis, or T1) and are in the ongoing maintenance phase of one of the eligible treatment programs
• (Phase 1b only) People who are able to have a catheter inserted and who have been able to tolerate their first bladder treatment at an outpatient clinic
• People who live within the area covered by the trial's supplier network
• People whose home has access to Wi-Fi or mobile data to support virtual telehealth appointments
• People aged 18 or older at the time of registration
• People who have signed the informed consent form for the trial
• People who are willing and able to follow the study protocol, as judged by the investigating doctor
• People who are able to complete questionnaires on their own or with help from someone else
• People who are willing to follow the required birth control guidelines (applicable to those who could potentially father or become pregnant)

Who may not be able to join:

• People who are receiving any other investigational or standard treatment for bladder cancer that is not one of the eligible treatment regimens listed in this trial
• People who are actively receiving treatment for any other cancer, except hormone therapy for breast or prostate cancer, or treatment for non-invasive skin cancer
• People who require around-the-clock assistance with basic daily activities such as eating, bathing, or dressing
• People who are currently admitted to a hospital (unless they are already enrolled in an Advanced Care at Home program)
• People who have other serious illnesses or conditions that, in the investigating doctor's judgment, would make participation unsafe or affect the accurate assessment of the treatment
• People with uncontrolled health conditions, including but not limited to: an active or ongoing infection, heart failure with symptoms, unstable chest pain, irregular heart rhythm, a heart attack within the past 6 months, a wound healing disorder, or a psychiatric or social situation that would make it difficult to follow the study requirements
• People who are expected to need major surgery during the course of the trial
• People who are known to have had an allergic reaction or intolerance to the drug regimens used in the trial
• People who are pregnant or breastfeeding
• People who have a known allergy or sensitivity to polysorbate 80 or paclitaxel (specific substances used in some medications)

Important: Always verify eligibility with the trial site directly before applying.